TNAP limits TGF-ß-dependent cardiac and skeletal muscle fibrosis by inactivating SMAD2/3 transcription factors (2019)
Attributed to:
Cell mediated gene therapy for muscular dystrophy: steps towards clinical efficacy.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1242/jcs.234948
PubMed Identifier: 31289197
Publication URI: http://europepmc.org/abstract/MED/31289197
Type: Journal Article/Review
Parent Publication: Journal of Cell Science
ISSN: 0021-9533